Press releases

07 August 2017

ARISE Clinical Trial half-time on the road

Patient inclusion to the ARISE trial is proceeding nicely. Figure 1 is showing the numbers of patients operated within the trial already as well as the number of scheduled operations. Therefore the ARISE consortium is confident... [more]

20 December 2016

Presentation at the STS/AATS Tech-Con on Saturday 21, 2017 in Houston, Texas about the ARISE study

The ARISE study will be presented at the Society of Thoracic Surgeons 53rd annual meeting during the STS/AATS Tech-Con on Saturday 21st in Houston, Texas (10:15-12:00 pm Adult Cardiac Track/Endovascular. Moderators: Michael... [more]

20 December 2016

ESPOIR project closing meeting held in Zurich in December 2016

Long-term follow up initiated - the European post-authorisation study on regenerative pulmonary heart valve replacement enrolled 120 patients [more]

02 May 2016

University of Barcelona second centre to start clinical trial on decellularized homografts for aortic valve replacement

A team of surgeons at the Hospital Clínic de Barcelona, led by Dr. Eduard Quintana (MD, PhD, FETCS), successfully performed the first implantation of a decellularized aortic homograft for aortic valve replacement in Spain. The... [more]

31 March 2016

3rd ARISE Steering Committee Meeting / Study start at second clinical centre upcoming

Members of the ARISE Steering Committee met in Venice on the 18th and 19th of March 2016 and discussed progress within the ARISE project, which focuses on decellularized homografts for aortic valve replacement. Within the... [more]

01 March 2016

New study on decellularized aortic homografts for aortic valve and aorta ascendens replacement published

Researchers from Hannover Medical School/Germany and the University Hospital in Chisinau/Moldavia have published the early results of decellularized aortic homografts (DAH) for aortic valve replacement (AVR) in February 2016... [more]

22 October 2015

Start of the ARISE clinical trial - First patient included at Hanover Medical School / EACTS 2015 Techno College Presentation

The ARISE clinical study has started in Hannover with the inclusion of the first patient, a 24-year-old man with severe aortic stenosis, due to a degenerated bioprosthesis,  and markedly reduced left ventricular... [more]

25 March 2015

Holding up under pressure: the MHH heads clinical study on lifelong aortic heart valve replacements EU awards 5 million Euro to the ARISE project

March 2015 saw the Kick-off Meeting of the EU-funded clinical study "Aortic Valve Replacement using Individualised Regenerative allografts: Bridging the Therapeutic Gap", which is to receive 5 million Euro in funding... [more]

30 January 2015

ESPOIR study start at KU Leuven / New EU-project ARISE

Belgian surgeons, led by Prof. Bart Meyns, successfully implanted the first ESPOIR PV valve within the ESPOIR study at the University hospital of the Katholieke Universiteit Leuven on the 22th of January 2015. KU Leuven... [more]

16 September 2014

Successful start for the ESPOIR study at Moldova State Medical University

A team of Moldavian surgeons, led by Prof. Anatol Ciubotaru, successfully operated the first patient in Chisinau/Mo on Wednesday, 03 September 2014. In an uneventful procedure, the young female patient received a decellularized... [more]

25 August 2014

ESPOIR clinical study start offers new hope for patients with congenital heart disease

A leading European consortium, headed by Hannover Medical School (MHH), has launched the ESPOIR clinical study on regenerative heart valves, with the first two enrolled patients undergoing valve replacement surgery at the MHH in... [more]

02 May 2014

No significant early activation of the cellular immune response after implantation of decellularized fresh pulmonary homografts

The longevity of homografts for heart valve replacement is determined by the amount of activation of the recipients' immune system caused by antigen reaction against the donated heart valve. Fresh decellularized pulmonary... [more]

02 May 2014

ESPOIR receives ENCePP Study Seal / ClinicalTrials.gov Identifier NCT02035540

The European Clinical Study for the Application of Regenerative Heart Valves received the ENCePP seal and has been officially registered in the ENCePP E-Register of Studies as a Post Authorization Safety Study (PASS), Ref. Number... [more]

09 October 2013

Third ESPOIR Steering Committee Meeting at the 2013 EACTS in Vienna / German authorities approved Espoir PV

The ESPOIR Steering Committee (SC) convened for the third time during the 27th EACTS Annual Meeting in Vienna. The German competent authority Paul-Ehrlich-Institut approved the study valve -ESPOIR PV-  a decellularized... [more]

12 November 2012

Steering Committee Meeting

The ESPOIR Steering Committee Meeting took place on 30th of October 2012 in Barcelona at the 26th EACTS Annual Meeting. During the Scientific Programme Prof. Haverich gave an update on the “Clinical results with in vitro unseeded... [more]

<< First < Previous 1-15 16-21 Next > Last >>